Tratamiento de cáncer pulmonar

Medina Morales, Frumencio; Barrera Rodríguez, Raúl; Rébora Togno, Fernando; Cerdan Assad, Alfredo; Zinser Sierra, Juan W; Gallardo Rincón, Dolores; Morales Fuentes, Jorge; Chavarría Garcés, Jorge; Echegoyen Carmona, Rufino; León Pérez, Fernando; Hernámdez Garduño, Eduardo.
Rev. Inst. Nac. Enfermedades Respir ; 8(4): 291-6, oct.-dic. 1995. tab
Artículo en Español | LILACS | ID: lil-167578

Documentos relacionados

  1. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: A systematic review.
  2. The effect of ambient PM<sub>2.5</sub> exposure on survival of lung cancer patients after lobectomy.
  3. Coffee Consumption and Risk of Lung Cancer: A Meta-Analysis of Prospective Cohort Studies.
  4. Treatment Patterns and Postoperative Activities of Daily Living in Patients with Non-small Cell Lung Cancer: A Retrospective Study Using Nationwide Health Services Utilization Data in Japan.
  5. Pairing smoking cessation with lung cancer screening may save lives.
  6. A global burden assessment of lung cancer attributed to residential radon exposure during 1990-2019.
  7. [Research progress on the association of occupational antimony exposure with lung cancer and its carcinogenic mechanism].
  8. Where there are fumes, there may be lung cancer: a systematic review on the association between exposure to cooking fumes and the risk of lung cancer in never-smokers.
  9. Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States.
  10. Analysis of immune-mediated reactions in patients with non-small cell lung cancer treated with nivolumab and its association with effectiveness.